[2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-propan-2-ylphenoxy)acetate

C16H20N2O5 — CID 30820093

IUPAC[2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-propan-2-ylphenoxy)acetate
SMILESCC(C)c1ccc(OCC(=O)OCC(=O)N2CCNC2=O)cc1
InChIInChI=1S/C16H20N2O5/c1-11(2)12-3-5-13(6-4-12)22-10-15(20)23-9-14(19)18-8-7-17-16(18)21/h3-6,11H,7-10H2,1-2H3,(H,17,21)
InChIKeyOVHGVBUKZHQDJB-UHFFFAOYSA-N
MW320.35 g/mol
LogP1.28
Rot. Bonds6

About [2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-propan-2-ylphenoxy)acetate

[2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-propan-2-ylphenoxy)acetate (PubChem CID 30820093) has the molecular formula C16H20N2O5 and a molecular weight of 320.35 g/mol. Its IUPAC name is [2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-propan-2-ylphenoxy)acetate.

Molecular Properties

Compound Name[2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-propan-2-ylphenoxy)acetate
PubChem CID30820093
Molecular FormulaC16H20N2O5
Molecular Weight320.35 g/mol
Exact Mass320.14
IUPAC Name[2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-propan-2-ylphenoxy)acetate
SMILESCC(C)c1ccc(OCC(=O)OCC(=O)N2CCNC2=O)cc1
InChIInChI=1S/C16H20N2O5/c1-11(2)12-3-5-13(6-4-12)22-10-15(20)23-9-14(19)18-8-7-17-16(18)21/h3-6,11H,7-10H2,1-2H3,(H,17,21)
InChIKeyOVHGVBUKZHQDJB-UHFFFAOYSA-N
XLogP1.28
TPSA84.94 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms23
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500320.35
LogP ≤ 51.28
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze [2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-propan-2-ylphenoxy)acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-benzoylphenoxy)acetate
CID 8925483
1-[2-(4-aminophenoxy)acetyl]imidazolidin-2-one
CID 54909200
[2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(2,6-dimethylphenoxy)acetate
CID 8527890
[2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(2-chlorophenoxy)acetate
CID 8908985
[2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-chloro-2,6-dimethylphenoxy)acetate
CID 8631255
[2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-methyl-2-oxochromen-7-yl)oxyacetate
CID 7844090
[2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] (2S)-2-(4-bromophenoxy)propanoate
CID 7742980
[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl] 2-(4-propan-2-ylphenoxy)acetate
CID 8597978
[2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-naphthalen-2-ylsulfanylacetate
CID 7795699
[2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-naphthalen-2-ylacetate
CID 7828549
[2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-phenylacetate
CID 7874639
1-[2-(3,5-dichlorophenoxy)acetyl]imidazolidin-2-one
CID 7467120

Frequently Asked Questions

What is the IUPAC name of [2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-propan-2-ylphenoxy)acetate?
The IUPAC name of [2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-propan-2-ylphenoxy)acetate (CID 30820093) is [2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-propan-2-ylphenoxy)acetate.
What is the SMILES notation for [2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-propan-2-ylphenoxy)acetate?
The canonical SMILES for [2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-propan-2-ylphenoxy)acetate is CC(C)c1ccc(OCC(=O)OCC(=O)N2CCNC2=O)cc1.
What is the InChIKey of [2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-propan-2-ylphenoxy)acetate?
The InChIKey is OVHGVBUKZHQDJB-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H20N2O5/c1-11(2)12-3-5-13(6-4-12)22-10-15(20)23-9-14(19)18-8-7-17-16(18)21/h3-6,11H,7-10H2,1-2H3,(H,17,21).
What are the key properties of [2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-propan-2-ylphenoxy)acetate?
[2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-propan-2-ylphenoxy)acetate has a molecular weight of 320.35 g/mol, XLogP of 1.28, 6 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [2-oxo-2-(2-oxoimidazolidin-1-yl)ethyl] 2-(4-propan-2-ylphenoxy)acetate is sourced from PubChem (CID 30820093), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).